The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.

Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12-15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a stand...

Full description

Bibliographic Details
Main Authors: Fahim Atif, Neil R Patel, Seema Yousuf, Donald G Stein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4482510?pdf=render

Similar Items